$30.97 0.14 (+0.45%)
2/9/2010 4:00 PM

Auxilium Pharmaceuticals, Inc. (AUXL)

CAPS Rating: 1 out of 5

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

Current Price $30.97 Mkt Cap $1.46B
Open $31.27 P/E Ratio 0.00
Prev. Close $30.83 Div. (Yield) N/A (N/A)
Daily Range $30.67 - $31.40 Volume 950,869
52-Wk Range $21.85 - $37.28 Avg. Daily Vol. 0

AUXL News and Commentary

Caps

How do you think AUXL will perform vs the S&P 500?

Add Stock to Watchlist

All Members

114 Outperform
65 Underperform
 

All-Star Members

22 Outperform
34 Underperform
 

Wall Street

11 Outperform
3 Underperform
 

Top AUXL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mblin13 (41.40)
Submitted March 01, 2007

downside provided by testim;
other drugs in phase 3 trials;
stock could triple

0 Comments | Reply | Report this Post

alvinbentley (99.94)
Submitted April 29, 2008

Do any investors out there know anything about Dupuytren's contracture? It is not very common. Most patients who need intervention would be referred to an orthopedic surgeon. If Xiaflex were actually FDA approved, the surgeon could recommend either… More

1 Comment | Reply | Report this Post
AUXL VS S&P 500 (SPY)

Fools bullish on AUXL are also bullish on:

Fools bearish on AUXL are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about AUXL.

Recs

0
Member Avatar EclecticRecluse (74.33) Submitted: 10/5/2009 5:17:05 PM : Underperform Start Price: $33.92 AUXL Score: +11.04

Negative Earnings Surprise

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar Ikeydoc (< 20) Submitted: 7/4/2009 11:40:46 AM : Outperform Start Price: $29.95 AUXL Score: -17.73

Release of treatment for Dupuytrens Disease

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar LexTNZorro (74.02) Submitted: 5/4/2009 3:21:31 AM : Outperform Start Price: $22.19 AUXL Score: +17.22

http://seekingalpha.com/article/133869-fda-clinical-trial-updates-watson-pharma-united-therapeutics-auxilium-dendreon?source=feed

Report this Post 0 Comments | Reply | Permalink
View All 18 Pitches »

Leaderboard

Find the members with the highest scoring picks in AUXL.

Score Leader

Weatheredwood

Weatheredwood (< 20) Score: +208.90

The Score Leader is the member with the highest score across all their picks in AUXL.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
Weatheredwood < 20 9/20/2006 Outperform 3M $10.50 +194.95% -13.95% +208.90
skyyhi < 20 10/17/2006 Outperform 1Y $12.14 +155.11% -16.53% +171.64
mblin13 41.40 3/1/2007 Outperform 3Y $12.32 +151.38% -19.17% +170.55 1 Comment
krishanl 39.62 1/16/2007 Outperform 1Y $13.97 +121.69% -20.46% +142.15
msraman < 20 1/29/2007 Outperform 1Y $14.00 +121.21% -19.96% +141.18
martinlemalin 62.21 1/22/2007 Outperform 1Y $14.20 +118.10% -20.45% +138.55 1 Comment
slash32is4 77.61 12/12/2006 Outperform NS $14.57 +112.56% -19.68% +132.24
727whi 25.83 6/5/2007 Outperform NS $15.37 +101.50% -26.11% +127.60
OneStarHero < 20 5/29/2007 Outperform 5Y $15.72 +97.01% -25.39% +122.40
SanjayChandran 48.82 7/9/2007 Outperform 1Y $16.08 +92.60% -26.18% +118.78
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackCarisandCo 86.28 7/20/2009 Underperform NS $29.22 +5.99% +13.78% +7.79
TrackHapoalim 23.78 6/25/2009 Outperform NS $27.78 +11.48% +20.15% -8.66
TrackZacks 62.21 5/6/2009 Outperform 3M $22.64 +49.82% +16.63% +33.20 10/13/2009 @ $33.92 1 Comment
TrackFTNEquityCa 65.55 4/1/2009 Underperform NS $23.28 +33.03% +35.19% +2.16
TrackFTNEquityCa 65.55 3/12/2009 Outperform NS $27.45 -11.73% +7.73% -19.46 4/1/2009 @ $24.23
TrackStanfordRes 85.54 11/14/2008 Outperform NS $22.09 +40.20% +23.02% +17.18
TrackLeerinkSwan 92.83 11/10/2008 Outperform NS $21.79 +42.13% +15.59% +26.54
TrackDeutscheSec 89.68 11/3/2008 Outperform NS $21.35 +45.06% +13.55% +31.51
TrackBreanMurray 86.47 9/30/2008 Underperform NS $33.28 -6.94% -3.29% +3.65
TrackOppenheimer 81.36 9/11/2008 Outperform NS $36.72 -15.66% -9.40% -6.26
TrackCollinsStew 68.03 8/13/2008 Outperform NS $40.73 -23.96% -13.98% -9.99
TrackPacificGrow 89.01 5/15/2008 Outperform NS $30.14 +2.75% -21.24% +24.00
TrackSoleil 93.91 3/24/2008 Outperform NS $22.50 +37.64% -16.59% +54.24
TrackMerriman < 20 3/24/2008 Underperform NS $22.50 +60.62% +5.60% -55.02 6/5/2008 @ $36.14
TrackJefferies 82.08 1/15/2008 Outperform NS $28.91 +7.13% -20.07% +27.19
TrackRothCapital 80.39 11/1/2007 Underperform NS $24.58 -13.14% -36.47% -23.33 11/3/2008 @ $21.35
TrackSoros 82.58 9/30/2007 Outperform NS $21.08 +46.92% -26.38% +73.29 1 Comment
TrackZacks 62.21 9/25/2007 Underperform 3M $20.40 +49.90% -2.46% -52.36 12/28/2007 @ $30.58 1 Comment
TrackCowenandCo 86.76 6/21/2007 Outperform NS $14.92 +107.57% -25.30% +132.87
TrackBofASec 94.61 5/25/2007 Outperform NS $16.57 +153.89% -14.66% +168.55 8/14/2008 @ $42.07
TrackCitigroup 85.92 5/10/2007 Outperform NS $13.87 +143.84% -15.27% +159.10 7/24/2008 @ $33.82
TrackRothCapital 80.39 11/20/2006 Underperform NS $16.71 -17.41% +3.73% +21.15 2/16/2007 @ $13.80

Featured Broker Partners